Skip to main content
SpringerLink
Log in

Grenzformen zwischen Typ-1- und Typ-2-Diabetes

Seminar / Diabetes

Latent autoimmune diabetes in adults

  • FORTBILDUNG -- SEMINAR
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Aktuell ist in Diskussion, ob die dichotome Einteilung in Typ-1- und Typ-2-Diabetes der Wirklichkeit gerecht wird. So sehen wir im Alltag zunehmend Überschneidungen zwischen diesen beiden Kategorien, und es entstehen Begriffe wie Doppel- und LADA-Diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Hawa MI & Action LADA 7 Consortium. Adult-Onset Autoimmune Diabetes in Europe is Prevalent with a broad Clinical Phenotype. Diabetes Care 2013; 36: 908–913

    Article  Google Scholar 

  2. Turner R et al. Prospective Diabetes Study Group, UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes, Lancet 1997; 350: 1288–1293

    Article  CAS  Google Scholar 

  3. Tuomi T et al. The many faces of diabetes: A disease with increasing heterogeneity. Lancet 2014; 383: 1084–94

    Article  Google Scholar 

  4. Fourlanos S, Dotta F, Greenbaum CJ, et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005; 48: 2206–12

    Article  CAS  Google Scholar 

  5. Zampetti S, Campagna G, Tiberti C, et al. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). Eur J Endocrinol 2014; 71: 697–704

    Article  Google Scholar 

  6. Hernandez M, Mollo A, Marsal JR, et al. Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9. BMC Endocr Disord 2015; 15: 1

    Article  Google Scholar 

  7. Pieralice S, Pozilli P. Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management. Diabetes Metab J 2018; 42: 451–464

    Article  Google Scholar 

  8. Maruyama T, et al. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. J Clin Endocrinol Metab 2008; 93: 2115–21

    Article  CAS  Google Scholar 

  9. Yang Z, et al. Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study. Diabetes Research and Clinical Practice 2009; 83: 54–60

    Article  CAS  Google Scholar 

  10. Zhao Y, Yang L, Xiang Y, et al. Dipeptidyl peptidase 4 inhibitor sitagliptin maintains ß-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study. J Clin Endocrinol Metab 2014; 99: E876–80

    Article  CAS  Google Scholar 

  11. Johansen OE, Boehm B, Grill V, et al. C-Peptide Levels in Latent Autoimmune Diabetes in Adults Treated With Linagliptin Versus Glimepiride: Exploratory results from a 2-year, double-blind, randomised, controlled study. Diabetes Care 2014; 37: e11–e12

    Article  CAS  Google Scholar 

  12. Pettus J, Hirsch I, Edelman S. GLP-1 agonists in type 1 diabetes. Clin Immunol 2013; 149: 317–23

    Article  CAS  Google Scholar 

  13. Pozzilli P, Leslie RD, Peters AL, et al. Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): a post-hoc analysis of the AWARD-2, -4 and -5 trials. Diabetes Obes Metab 2018; 20: 1490–8

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetologische Schwerpunktpraxis Rosenheim, Max-Josefs-Platz 21, D-83022, Rosenheim, Deutschland

    Michael Hummel

Authors
  1. Michael Hummel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Hummel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hummel, M. Grenzformen zwischen Typ-1- und Typ-2-Diabetes. MMW - Fortschritte der Medizin 162, 60–63 (2020). https://doi.org/10.1007/s15006-020-0577-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-020-0577-6

Keywords

Search

Navigation